A Pilot Study - Safety and Efficacy of Nailprotex® for Onychomycosis Treatment
1 other identifier
interventional
19
1 country
1
Brief Summary
This study was designed to demonstrate the efficacy of this product in non-dermatophyte (Scytalidium dimidiatum) onychomycosis and chronic paronychia treatment in Thai patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_4
Started Jul 2015
Shorter than P25 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 30, 2015
CompletedFirst Posted
Study publicly available on registry
June 8, 2015
CompletedStudy Start
First participant enrolled
July 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2016
CompletedJune 17, 2016
June 1, 2016
11 months
April 30, 2015
June 16, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The change in the severity of onychomycosis by using SCIO (Scoring Clinical Index for Onychomycosis) score from baseline and 6 months-after using Nailprotex®
Patients who were treated by Nailprotex® in this study were evaluated the severity of onychomycosis by using SCIO (Scoring Clinical Index for Onychomycosis) score at baseline and after using Nailprotex® 6 months. Then the change in SCIO score was analyzed in percentage and compare mean.
6 months
Secondary Outcomes (2)
The side effects of Nailprotex®
6 months
Mycological cure rate which mean KOH and fungal culture result are both nagative after using Nailprotex® at 6 month after treated with Nailprotex®
6 months
Study Arms (1)
Edit arms
EXPERIMENTALNailprotex apply to the abnormal nail twice daily
Interventions
Eligibility Criteria
You may qualify if:
- Male or female participants was 18 years old or above.
- Participants were diagnosed Scytalidium dimidiatum onychomycosis or chronic paronychia by dermatologists based on clinical presentation and mycological identification.
- Participants accept the aim of this project and sign the consent form by themselves.
You may not qualify if:
- Participants have other nail disorders before participate the research.
- Participants have the history of immunocompromised host.
- Participants were diagnosed onychomycosis more than 3 nails or matrix involvement.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Dermatology Siriraj Hospital
Bangkoknoi, Bangkok, 10700, Thailand
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Charussri - Leeyaphan, MD.
Department of Dermatology Faculty of Medicine, Siriraj Hospital Mahidol University
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 30, 2015
First Posted
June 8, 2015
Study Start
July 1, 2015
Primary Completion
June 1, 2016
Study Completion
June 1, 2016
Last Updated
June 17, 2016
Record last verified: 2016-06